Drugs that contain Megestrol Acetate
1. List of Megace Es drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7101576 | ENDO PHARMS INC | Nanoparticulate megestrol formulations |
Apr, 2024
(1 year, 26 days from now) | |
| US9101540 | ENDO PHARMS INC | Nanoparticulate megestrol formulations |
Apr, 2024
(1 year, 26 days from now) | |
| US9107827 | ENDO PHARMS INC | Nanoparticulate megestrol formulations |
Apr, 2024
(1 year, 26 days from now) | |
| US9040088 | ENDO PHARMS INC | Nanoparticulate megestrol formulations |
Apr, 2024
(1 year, 26 days from now) | |
| US9101549 | ENDO PHARMS INC | Nanoparticulate megestrol formulations |
Apr, 2024
(1 year, 26 days from now) | |
Market Authorisation Date: 05 July, 2005
Treatment: Treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids)
Dosage: SUSPENSION;ORAL
How can I launch a generic of MEGACE ES before it's patent expiration?
More Information on Dosage
MEGACE ES family patents
20
United States
6
European Union
5
Japan
3
Canada
3
Australia
1
Slovenia
1
Brazil
1
Portugal
1
South Africa
1
Denmark
1
Cyprus
1
EA
1
Mexico
1
Spain
1
Austria
1
Norway
1
Korea, Republic of
1
China
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic